Norway, Sweden, Denmark, Finland — digital health hub.
| Company |
Category |
Funding |
Status
|
| Noteless |
AI Clinical Documentation |
EUR 3.5M Seed |
Active, 3,000+ clinicians
|
| Dr. Dropin |
Digi-Physical Healthcare |
EUR 19.2M |
Expanding to London
|
| Nolla Health |
AI Dermatology |
$4.5M |
Launched in US
|
| Actithera |
Radiopharma |
$75.5M Series A |
Pipeline development
|
| Dignio |
Remote Patient Monitoring |
Acquired by Summa Equity |
NHS pilot in UK
|
| Holberg EEG |
AI Neurodiagnostics |
Acquired by Natus |
Global autoSCORE launch
|
| Lioness Medtech |
Portable MRI |
Partnership |
First portable MRI in Norway
|
| No Isolation |
Social Impact Robots |
Undisclosed |
Deployed in UK+
|
| Journalia |
AI Healthcare Admin |
$1M |
Early stage
|
| Company |
Category |
Funding |
Status
|
| Neko Health |
Preventive Health / AI Scanning |
$260M ($1.8B val) |
Stockholm, London, NYC
|
| Tandem Health |
AI Clinical OS |
EUR 42.6M Series A |
200K+ NHS staff, 5 EU markets
|
| Kry / Livi |
Telehealth |
$316M+ (~$2B val) |
Profitable, 5 countries
|
| Mindler |
Digital Mental Health |
$8.7M |
Acquired ieso UK, Medified FI
|
| Acorai |
Cardiac Monitoring |
EUR 4.2M+ |
FDA Breakthrough Device
|
| Dentio |
AI Dental |
$2.3M (a16z) |
Early stage
|
| Cellcolabs |
Stem Cell Mfg |
$12M |
Bryan Johnson-backed
|
| Meela |
Patient-Therapist Match |
EUR 2.6M Seed |
Gothenburg
|
| Sakura |
B2B Mental Health |
Pre-seed |
Female-founded
|
| TrialMe |
Femtech / Clinical Trials |
Undisclosed |
Gender gap in trials
|
| Loovi |
Preventive Health |
EUR 1M |
Early stage
|
| Doctrin |
Digital Primary Care |
Undisclosed |
New CEO, UK expansion
|
| Min Doktor |
Online Healthcare |
EUR 4.7M |
Struggling to scale
|
| BOOST Pharma |
Cell Therapy |
EUR 3.1M+ |
RoslinCT partnership
|
| Nyctea Technologies |
Biotech / Drug Dev |
Undisclosed |
Chalmers Ventures, Gothenburg
|
Denmark[edit]
| Company |
Category |
Funding |
Status
|
| VentriJect |
Cardiac Monitoring |
EUR 1.7M |
Siesmofit system, UN demo
|
| Hemi Health |
Migraine/Concussion |
EUR 4M |
Female-led, international expansion
|
Finland[edit]
| Company |
Category |
Funding |
Status
|
| Audicin |
Neurowellness / Wearables |
$1.9M |
Nervous system real-time monitoring
|
Funding & Support[edit]
Key Topics[edit]
Ecosystem Notes[edit]
Sweden significantly ahead in funding and unicorns. Norway more device/RPM focused. Denmark emerging with VentriJect and Hemi Health. Finland growing via Maria 01 campus with 3x funding growth in 2025. Actithera's $75.5M is largest Norwegian health raise. a16z entering Nordics via Dentio. Novo Nordisk Foundation granted DKK 5.5B for innovation.
